CD274 and head and neck squamous cell carcinoma: Therefore, in our opinion, in contrast to other solid cancers, the immunotherapy efficacy and prognosis of HNSCC might be determined by a combination of multiple factors, including the TIDE score, PD-L1 expression, TMB scores, and risk scores.